Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Transplant. Jun 18, 2025; 15(2): 99208
Published online Jun 18, 2025. doi: 10.5500/wjt.v15.i2.99208
Table 2 Cardiac workup and pharmacoeconomic analysis1, n (%)
Variable
Entire cohort (n = 342)
Patients with CAR-OLT scores ≤ 23 (n = 84)
Potential saving (€)
Potential saving (€) per patient
Exercise electrocardiogram
Tests performed54/342 (15.8)18/84 (21.4)1004.4011.95
Doubtful/positive result (on valid tests)9/44 (20.4)5/13 (38.5)
Stress myocardial perfusion imaging
Tests performed206/342 (60.2)58/84 (69)17864212.66
Doubtful/positive result68/206 (33)12/58 (20.7)
Stress echocardiogram
Test performed14/342 (4.1)2/84 (2.4)140€1.66€
Doubtful/positive result1/14 (7.1)0
Coronary computed tomography angiography
Tests performed34/342 (9.9)9/84 (10.7)1422€16.93€
Significant stenosis4/34 (11.8)1/9 (11.1)
Coronary angiography
Test performed80/342 (23.4)13/84 (15.5)27846€331.5€
Significant stenosis25/80 (31.2)3/13 (23.1)
1 vessel101
2 vessels90
3 vessels62
Myocardial revascularization
Percutaneous coronary intervention111
Coronary artery bypass11
Right heart catheterization111-
Cardiac contraindications to listing21/342 (6.1)2/84 (2.4)
Coronary artery disease101
Valvular heart disease40
Severe pulmonary hypertension31
Atrial fibrillation associated with left ventricular ejection fraction < 45%40
Overall diagnostic work-up388 diagnostic exams100 diagnostic exams48276.40€574.70€